TY - JOUR
T1 - A C3(H20) recycling pathway is a component of the intracellular complement system
AU - Elvington, Michelle
AU - Liszewski, M. Kathryn
AU - Bertram, Paula
AU - Kulkarni, Hrishikesh S.
AU - Atkinson, John P.
N1 - Funding Information:
Acknowledgments Support was provided by the NIH (R01 GM0099111 and R01 AI041592 to JPA), an NIH Training grant in the Immunobiology of Rheumatic Disease (2T32 AR007279 to ME), and an NIH Training grant in the Principles of Pulmonary Research (5T32 HL007317 to HSK). Research reported in this publication is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the NIH (P30AR048335) and an NIH grant for the Washington University Institute of Clinical and Translational Sciences (3UL1 TR000448). The authors thank Richard Hauhart for preparing the purified C3 and Wandy Beatty and Brian Anthony in the Molecular Microbiology Imaging Facility at WUSM for expert technical assistance with confocal microscopy.
PY - 2017/3/1
Y1 - 2017/3/1
N2 - An intracellular complement system (ICS) has recently been described in immune and nonimmune human cells. This system can be activated in a convertase-independent manner from intracellular stores of the complement component C3. The source of these stores has not been rigorously investigated. In the present study, Western blotting identified a band corresponding to C3 in freshly isolated human peripheral blood cells that was absent in corresponding cell lines. One difference between native cells and cell lines was the time absent from a fluid-phase complement source; therefore, we hypothesized that loading C3 from plasma was a route of establishing intracellular C3 stores. We found that many types of human cells specifically internalized C3(H2O), the hydrolytic product of C3, and not native C3, from the extracellular milieu. Uptake was rapid, saturable, and sensitive to competition with unlabeled C3(H2O), indicating a specific mechanism of loading. Under steadystate conditions, approximately 80% of incorporated C3(H2O) was returned to the extracellular space. These studies identify an ICS recycling pathway for C3(H2O). The loaded C3(H2O) represents a source of C3a, and its uptake altered the cytokine profile of activated CD4+ T cells. Importantly, these results indicate that the impact of soluble plasma factors should be considered when performing in vitro studies assessing cellular immune function.
AB - An intracellular complement system (ICS) has recently been described in immune and nonimmune human cells. This system can be activated in a convertase-independent manner from intracellular stores of the complement component C3. The source of these stores has not been rigorously investigated. In the present study, Western blotting identified a band corresponding to C3 in freshly isolated human peripheral blood cells that was absent in corresponding cell lines. One difference between native cells and cell lines was the time absent from a fluid-phase complement source; therefore, we hypothesized that loading C3 from plasma was a route of establishing intracellular C3 stores. We found that many types of human cells specifically internalized C3(H2O), the hydrolytic product of C3, and not native C3, from the extracellular milieu. Uptake was rapid, saturable, and sensitive to competition with unlabeled C3(H2O), indicating a specific mechanism of loading. Under steadystate conditions, approximately 80% of incorporated C3(H2O) was returned to the extracellular space. These studies identify an ICS recycling pathway for C3(H2O). The loaded C3(H2O) represents a source of C3a, and its uptake altered the cytokine profile of activated CD4+ T cells. Importantly, these results indicate that the impact of soluble plasma factors should be considered when performing in vitro studies assessing cellular immune function.
UR - http://www.scopus.com/inward/record.url?scp=85015879754&partnerID=8YFLogxK
U2 - 10.1172/JCI89412
DO - 10.1172/JCI89412
M3 - Article
C2 - 28192370
AN - SCOPUS:85015879754
SN - 0021-9738
VL - 127
SP - 970
EP - 981
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 3
ER -